Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SY vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SY
So-Young International Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • CN
Market Cap$198M
5Y Perf.-67.4%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%

SY vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SY logoSY
ISRG logoISRG
IndustryMedical - Healthcare Information ServicesMedical - Instruments & Supplies
Market Cap$198M$161.07B
Revenue (TTM)$1.43B$10.58B
Net Income (TTM)$-741M$2.98B
Gross Margin51.6%66.3%
Operating Margin-53.2%30.5%
Forward P/E43.8x
Total Debt$240M$303M
Cash & Equiv.$588M$3.37B

SY vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SY
ISRG
StockMay 20May 26Return
So-Young Internatio… (SY)10032.6-67.4%
Intuitive Surgical,… (ISRG)100234.6+134.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: SY vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. So-Young International Inc. is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
SY
So-Young International Inc.
The Income Pick

SY is the clearest fit if your priority is dividends and momentum.

  • 1.6% yield; 1-year raise streak; the other pay no meaningful dividend
  • +266.1% vs ISRG's -15.4%
Best for: dividends and momentum
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 1.02
  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.5% 10Y total return vs SY's -82.9%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs SY's -2.1%
Quality / MarginsISRG logoISRG28.2% margin vs SY's -51.8%
Stability / SafetyISRG logoISRGBeta 1.02 vs SY's 2.05, lower leverage
DividendsSY logoSY1.6% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)SY logoSY+266.1% vs ISRG's -15.4%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs SY's -28.0%, ROIC 15.0% vs -24.1%

SY vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SYSo-Young International Inc.
FY 2023
Services And Others
100.0%$386M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

SY vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGSY

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 6 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 7.4x SY's $1.4B. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to SY's -51.8%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSY logoSYSo-Young Internat…ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$1.4B$10.6B
EBITDAEarnings before interest/tax-$751M$3.8B
Net IncomeAfter-tax profit-$741M$3.0B
Free Cash FlowCash after capex$0$2.8B
Gross MarginGross profit ÷ Revenue+51.6%+66.3%
Operating MarginEBIT ÷ Revenue-53.2%+30.5%
Net MarginNet income ÷ Revenue-51.8%+28.2%
FCF MarginFCF ÷ Revenue-6.0%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+4.0%+23.0%
EPS Growth (YoY)Latest quarter vs prior year-4.3%+18.8%
ISRG leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

SY leads this category, winning 3 of 3 comparable metrics.
MetricSY logoSYSo-Young Internat…ISRG logoISRGIntuitive Surgica…
Market CapShares × price$198M$161.1B
Enterprise ValueMkt cap + debt − cash$147M$158.0B
Trailing P/EPrice ÷ TTM EPS-4.68x57.62x
Forward P/EPrice ÷ next-FY EPS est.43.84x
PEG RatioP/E ÷ EPS growth rate2.65x
EV / EBITDAEnterprise value multiple43.62x
Price / SalesMarket cap ÷ Revenue0.92x16.00x
Price / BookPrice ÷ Book value/share1.41x9.17x
Price / FCFMarket cap ÷ FCF64.67x
SY leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 7 of 8 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for SY. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SY's 0.12x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs SY's 2/9, reflecting solid financial health.

MetricSY logoSYSo-Young Internat…ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity-41.4%+16.9%
ROA (TTM)Return on assets-28.0%+14.8%
ROICReturn on invested capital-24.1%+15.0%
ROCEReturn on capital employed-26.1%+16.5%
Piotroski ScoreFundamental quality 0–926
Debt / EquityFinancial leverage0.12x0.02x
Net DebtTotal debt minus cash-$348M-$3.1B
Cash & Equiv.Liquid assets$588M$3.4B
Total DebtShort + long-term debt$240M$303M
Interest CoverageEBIT ÷ Interest expense
ISRG leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $3,530 for SY. Over the past 12 months, SY leads with a +266.1% total return vs ISRG's -15.4%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs SY's 3.6% — a key indicator of consistent wealth creation.

MetricSY logoSYSo-Young Internat…ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date+13.1%-19.3%
1-Year ReturnPast 12 months+266.1%-15.4%
3-Year ReturnCumulative with dividends+11.3%+49.6%
5-Year ReturnCumulative with dividends-64.7%+58.7%
10-Year ReturnCumulative with dividends-82.9%+554.2%
CAGR (3Y)Annualised 3-year return+3.6%+14.4%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

ISRG leads this category, winning 2 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than SY's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 75.1% from its 52-week high vs SY's 48.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSY logoSYSo-Young Internat…ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5002.05x1.02x
52-Week HighHighest price in past year$6.28$603.88
52-Week LowLowest price in past year$0.80$427.84
% of 52W HighCurrent price vs 52-week peak+48.1%+75.1%
RSI (14)Momentum oscillator 0–10065.742.4
Avg Volume (50D)Average daily shares traded457K1.8M
ISRG leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates SY as "Buy" and ISRG as "Buy". Consensus price targets imply 37.3% upside for ISRG (target: $623) vs -73.5% for SY (target: $1). SY is the only dividend payer here at 1.58% yield — a key consideration for income-focused portfolios.

MetricSY logoSYSo-Young Internat…ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$0.80$622.60
# AnalystsCovering analysts555
Dividend YieldAnnual dividend ÷ price+1.6%
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS$0.32
Buyback YieldShare repurchases ÷ mkt cap+1.4%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SY leads in 1 (Valuation Metrics).

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 4 of 6 categories
Loading custom metrics...

SY vs ISRG: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is SY or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -2. 1% for So-Young International Inc. (SY). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 6x trailing P/E (43. 8x forward), making it the more compelling value choice. Analysts rate So-Young International Inc. (SY) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SY or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -64. 7% for So-Young International Inc. (SY). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus SY's -82. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SY or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus So-Young International Inc. 's 2. 05β — meaning SY is approximately 102% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 12% for So-Young International Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — SY or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -2. 1% for So-Young International Inc. (SY). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -28. 4% for So-Young International Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SY or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -40. 2% for So-Young International Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -42. 6% for SY. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is SY or ISRG more undervalued right now?

Analyst consensus price targets imply the most upside for ISRG: 37.

3% to $622. 60.

07

Which pays a better dividend — SY or ISRG?

In this comparison, SY (1.

6% yield) pays a dividend. ISRG does not pay a meaningful dividend and should not be held primarily for income.

08

Is SY or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +554. 2% 10Y return). So-Young International Inc. (SY) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +554. 2%, SY: -82. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between SY and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SY is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock. SY pays a dividend while ISRG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SY

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 30%
  • Dividend Yield > 0.6%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SY and ISRG on the metrics below

Revenue Growth>
%
(SY: 4.0% · ISRG: 23.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.